Filing Details
- Accession Number:
- 0000950170-24-035162
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-22 11:26:40
- Reporting Period:
- 2024-03-20
- Accepted Time:
- 2024-03-22 11:26:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
19584 | Chemed Corp | CHE | Services-Home Health Care Services (8082) | 310791746 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1823398 | C Brian Judkins | 255 East Fifth Street Suite 2600 Cincinnati OH 45202 | Vp And Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Capital Stock | Acquisiton | 2024-03-20 | 5,825 | $413.19 | 6,447 | No | 4 | M | Direct | |
Capital Stock | Acquisiton | 2024-03-20 | 6,133 | $471.74 | 12,580 | No | 4 | M | Direct | |
Capital Stock | Disposition | 2024-03-20 | 11,158 | $645.00 | 1,422 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Capital Stock | Stock option (right to buy with tandem tax withholding) | Disposition | 2024-03-20 | 5,825 | $413.19 | 5,825 | $413.19 |
Capital Stock | Stock Option (right to buy with tandem tax withholding) | Disposition | 2024-03-20 | 6,133 | $471.74 | 6,133 | $471.74 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
29,183 | 2024-10-29 | No | 4 | M | Direct | |
23,050 | 2025-10-29 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiples transactions at prices ranging from $642.00 to $649.00. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.
- Vesting in three equal annual installments commencing 10/29/2020
- Vesting in three equal annual installments commencing 10/29/2021